According to Epitan's website the US market for solarium use is $8 Billion a year. So I guess that world wide solarium use would be say...$20 Billion. Lets say that the fake tan industry is about $4 Billion a year.
That makes $24 Billion that people spend on tanning each year worldwide.
Considering that melanotan will is a vastly superior product to either solariums or fake tans, lets be conservative and say that Epitan will take say 30% (I reckon it will end up being close to 100%) of this $24 Billion. This equals $7.2 Billion.
And there will heaps of people that would like a tan but wont risk cancer for it- say another $3 Billion.
Total income = $10.2 Billion
Lets say they pay their JV partner $2.2 Billion for manufacturing and distribution.
That leaves $8 Billion
Minus $1 Billion for costs (stationary, toilet paper, coffee and tea for the tearoom and Office parties)
Leaves $7 Billion. Subtract 30% company tax
Leaves $4.9 Billion
When companies become cashflow positive they do one or more of the following:
1) Reinvest the profits into expansion or further R & D. (Smart companies get >$1 for every dollar reinvested and dumb ones get <$1 for every dollar invested.
2) Reward the share holders (dividends)
3) Share buybacks
4) Rape and pillage the company- then piss off to Spain.
Lets assume that buy this stage the company will have issued another 40 million shares - bringing the total number of shares to about 150 million. If $4 Billion gets returned to share holders (with $900 million in bonuses for the lab rats and directors) that means a annual dividend of $26.67 per share!
At say a 8% yeild that makes a share price of $333. If they take 60% of the market that makes $667 per share. Someone please slap some sense into me!
I think the figures I have used are huge but not unrealistic.
Have I missed anything? Any comments?
.....Assuming the trials work!
- Forums
- ASX - By Stock
- now for some maths...
According to Epitan's website the US market for solarium use is...
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.70 |
Change
0.120(0.88%) |
Mkt cap ! $685.8M |
Open | High | Low | Value | Volume |
$13.53 | $13.76 | $13.42 | $747.9K | 54.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 233 | $13.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.71 | 19 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 233 | 13.640 |
1 | 233 | 13.630 |
1 | 233 | 13.610 |
1 | 233 | 13.600 |
1 | 1000 | 13.500 |
Price($) | Vol. | No. |
---|---|---|
13.710 | 19 | 1 |
13.750 | 233 | 1 |
13.760 | 233 | 1 |
13.780 | 233 | 1 |
13.790 | 233 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online